These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 25921556)
1. Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study. Rivera-Navarro J; Cubo E; Mariscal N J Genet Couns; 2015 Dec; 24(6):1011-21. PubMed ID: 25921556 [TBL] [Abstract][Full Text] [Related]
2. Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives. Taylor SD Soc Sci Med; 2004 Jan; 58(1):137-49. PubMed ID: 14572927 [TBL] [Abstract][Full Text] [Related]
3. Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making. Arning L; Witt CN; Epplen JT; Stemmler S J Huntingtons Dis; 2015; 4(1):87-98. PubMed ID: 26333260 [TBL] [Abstract][Full Text] [Related]
4. [Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease]. Jakobsen LB; Malt U; Nilsson B; Rosenlund S; Heiberg A Tidsskr Nor Laegeforen; 1999 May; 119(13):1913-6. PubMed ID: 10382341 [TBL] [Abstract][Full Text] [Related]
5. 22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium. Baig SS; Strong M; Rosser E; Taverner NV; Glew R; Miedzybrodzka Z; Clarke A; Craufurd D; ; Quarrell OW Eur J Hum Genet; 2016 Oct; 24(10):1396-402. PubMed ID: 27165004 [TBL] [Abstract][Full Text] [Related]
6. Huntington's disease in Greece: the experience of 14 years. Panas M; Karadima G; Vassos E; Kalfakis N; Kladi A; Christodoulou K; Vassilopoulos D Clin Genet; 2011 Dec; 80(6):586-90. PubMed ID: 21166788 [TBL] [Abstract][Full Text] [Related]
8. Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing. Ramos-Arroyo MA; Moreno S; Valiente A J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):337-42. PubMed ID: 15716522 [TBL] [Abstract][Full Text] [Related]
9. Psychological reactions to predictive genetic testing for Huntington's disease: A qualitative study. Tillerås KH; Kjoelaas SH; Dramstad E; Feragen KB; von der Lippe C J Genet Couns; 2020 Dec; 29(6):1093-1105. PubMed ID: 32162754 [TBL] [Abstract][Full Text] [Related]
10. United Kingdom experience with presymptomatic testing of individuals at 25% risk for Huntington's disease. Benjamin CM; Lashwood A Clin Genet; 2000 Jul; 58(1):41-9. PubMed ID: 10945660 [TBL] [Abstract][Full Text] [Related]
11. Personal factors associated with reported benefits of Huntington disease family history or genetic testing. Williams JK; Erwin C; Juhl A; Mills J; Brossman B; Paulsen JS; Genet Test Mol Biomarkers; 2010 Oct; 14(5):629-36. PubMed ID: 20722493 [TBL] [Abstract][Full Text] [Related]
12. Psychological distress in the 5-year period after predictive testing for Huntington's disease. Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP Eur J Hum Genet; 2003 Jan; 11(1):30-8. PubMed ID: 12529703 [TBL] [Abstract][Full Text] [Related]
13. Huntington's disease: prenatal screening for late onset disease. Post SG J Med Ethics; 1992 Jun; 18(2):75-8. PubMed ID: 1535662 [TBL] [Abstract][Full Text] [Related]
14. Family Communication Patterns and Challenges of Huntington's Disease Risk, the Decision to Pursue Presymptomatic Testing, and Test Results. Stuttgen K; Bollinger J; McCague A; Dvoskin R; Mathews D J Huntingtons Dis; 2020; 9(3):265-274. PubMed ID: 32568103 [TBL] [Abstract][Full Text] [Related]
15. Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer. van der Meer LB; van Duijn E; Wolterbeek R; Tibben A Clin Genet; 2012 Jan; 81(1):18-23. PubMed ID: 21895638 [TBL] [Abstract][Full Text] [Related]
16. Intentions to use predictive testing by those at risk for Huntington's disease: implications for prevention. Meissen GJ; Berchek RL Am J Community Psychol; 1988 Apr; 16(2):261-77. PubMed ID: 2970219 [TBL] [Abstract][Full Text] [Related]
17. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Creighton S; Almqvist EW; MacGregor D; Fernandez B; Hogg H; Beis J; Welch JP; Riddell C; Lokkesmoe R; Khalifa M; MacKenzie J; Sajoo A; Farrell S; Robert F; Shugar A; Summers A; Meschino W; Allingham-Hawkins D; Chiu T; Hunter A; Allanson J; Hare H; Schween J; Collins L; Sanders S; Greenberg C; Cardwell S; Lemire E; MacLeod P; Hayden MR Clin Genet; 2003 Jun; 63(6):462-75. PubMed ID: 12786753 [TBL] [Abstract][Full Text] [Related]
18. What to Do with a Second Chance in Life? Long-Term Experiences of Non-carriers of Huntington's Disease. Winnberg E; Winnberg U; Pohlkamp L; Hagberg A J Genet Couns; 2018 Dec; 27(6):1438-1446. PubMed ID: 29626325 [TBL] [Abstract][Full Text] [Related]
19. Huntington's disease. Part 3: family aspects of HD. Aubeeluck A; Moskowitz CB Br J Nurs; 2008 Mar 13-26; 17(5):328-31. PubMed ID: 18414297 [TBL] [Abstract][Full Text] [Related]
20. Attachment in families with Huntington's disease. A paradigm in clinical genetics. Van der Meer L; Timman R; Trijsburg W; Duisterhof M; Erdman R; Van Elderen T; Tibben A Patient Educ Couns; 2006 Oct; 63(1-2):246-54. PubMed ID: 16427763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]